Skip to main content

Market Overview

10 Stocks Moving In Tuesday's Pre-Market Session

Share:


Gainers

Celator Pharmaceuticals Inc (NASDAQ: CPXX) shares gained 447.62 percent to $9.20 in pre-market trading following announcement Monday of positive results in Phase 3 trial for Vyxeos in patients with high risk acute myeloid leukemia.

Solazyme Inc (NASDAQ: SZYM) shares rose 33.68 percent to $2.54 in pre-market trading following the announcement of the company's fourth quarter results. The micro-cap renewable oils and bioproducts producer delivered adjusted loss of $(0.32) per share, on revenue of $10.39 million

Outerwall Inc (NASDAQ: OUTR) shares gained 13.41 percent to $39.00 in pre-market trading following news for investors the company has begun the process of exploring strategic and financial alternatives. Outerwall's Board also announced the raising of the company's quarterly dividend from $0.30 to $0.60 per share.

Videocon d2h Ltd - ADR (NASDAQ: VDTH) shares rose 9.81 percent to $7.50 in pre-market trading after gaining 4.12 percent on Monday.

RetailMeNot Inc (NASDAQ: SALE) rose 8.40 percent to $8.65 in pre-market trading after dropping 2.68 percent on Monday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

Immunomedics, Inc. (NASDAQ: IMMU) shares fell 15.09 percent to $2.25 in pre-market trading after announcing it is terminating its Phase 3 PANCRIT-1 trial with yttrium-90-labeled (90Y) clivatuzumab tetraxetan in patients with metastatic pancreatic cancer who had received at least two prior therapies, one of which must have been a gemcitabine-containing regimen.

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares fell 14.96 percent to $58.68 in pre-market trading after the company reported downbeat Q4 earnings and lowered its full-year outlook.

Alere Inc (NYSE: ALR) shares fell 8.88 percent to $48.75 in pre-market trading following a new delay in 10K filing and announcement of subpoena from the U.S. Department of Justice.

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) shares fell 3.71 percent to $20.25 in pre-market trading after surging 149.17 percent on Monday.

Momo Inc (ADR) (NASDAQ: MOMO) shares fell 3.50 percent to $12.70 in pre-market trading. Momo reported Q4 non-GAAP diluted earnings of $0.06 per ADS on revenue of $39.5 million.

 

Related Articles (SZYM + CPXX)

View Comments and Join the Discussion!

Posted-In: #PreMarket Gainers #PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com